Clinical Trials Browser

Withdrawn × Sulindac × Clear all

NCT01843179 2017-02-17

Sulindac for Patients With AML

Phase 2 Withdrawn

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Withdrawn

Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli

NCT01636128 2014-07-30

Urinary Biomarker Study With Sulindac and Difluoromethylornithine

Phase 2 Withdrawn

Neoplasms